Potential usefulness of [123I]I-MIBG SPECT/CT with AC Quant protocols in diagnostics and treatment monitoring of children with neuroblastoma
Nuclear Medicine Review · 20.04.2026 · 29
DOI: 10.5603/nmr.110976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Medicine Review, online erschienen am 20.04.2026. Verfasst von Anna Śliwińska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Children's Memorial Health Institute, Warsaw, Poland. Hauptthemen laut MEDLINE: Neuroblastoma, 3-Iodobenzylguanidine, Single Photon Emission Computed Tomography Computed Tomography.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Children's Memorial Health Institute, Warsaw, Poland.
- Department of Nuclear Medicine, Children's Memorial Health Institute, Warsaw, Poland. k.switaj@ipczd.pl.
- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
ORCID-Profile: Anna Śliwińska, Karolina Świtaj, Adam Daniel Durma
Zitieren
APA
Śliwińska, A., Świtaj, K., & Durma, A. D. (2026). Potential usefulness of [123I]I-MIBG SPECT/CT with AC Quant protocols in diagnostics and treatment monitoring of children with neuroblastoma. Nuclear Medicine Review, 29(0). https://doi.org/10.5603/nmr.110976
Vancouver
Śliwińska A, Świtaj K, Durma AD. Potential usefulness of [123I]I-MIBG SPECT/CT with AC Quant protocols in diagnostics and treatment monitoring of children with neuroblastoma. Nuclear Medicine Review. 2026;29(0). doi:10.5603/nmr.110976
BibTeX
@article{liwiska2026,
author = {Śliwińska, Anna and Świtaj, Karolina and Durma, Adam Daniel},
title = {Potential usefulness of [123I]I-MIBG SPECT/CT with AC Quant protocols in diagnostics and treatment monitoring of children with neuroblastoma},
journal = {Nuclear Medicine Review},
year = {2026},
volume = {29},
number = {0},
doi = {10.5603/nmr.110976}
}
EUVIMED